Jordan Rich Fills in - Various biotech companies have been competing for who will come up with the first most effective COVID-19 vaccine. Last week Pfizer reported it had a vaccine that reached a 90% effectiveness in its late stage trials and this week Moderna, a Boston based biotech company, reported its vaccine to have a 94.5% effectiveness in late stage trials. Here to discuss future vaccine distribution and how it would change our country is the President and CEO of the Massachusetts Biotechnology Council, Robert Coughlin.